SummitTX Capital’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.6M Buy
+41,163
New +$4.72M 0.12% 203

Other funds holding KYMR

SummitTX Capital's KYMR Position: Q3 2026 in Review

SummitTX Capital opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 41,163 shares worth $4.6M. The stake represents 0.12% of the portfolio and ranks #203 among its holdings.

301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • SummitTX Capital held 41,163 shares of Kymera Therapeutics worth $4.6M as of Q3 2026.
  • Kymera Therapeutics was a new SummitTX Capital position in Q3 2026.
  • Kymera Therapeutics made up 0.12% of SummitTX Capital's portfolio in Q3 2026, its #203 holding.
  • 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.